Literature DB >> 8280819

The extent and pattern of gastro-oesophageal reflux in patients with scleroderma oesophagus: the effect of low-dose omeprazole.

J P Shoenut1, J A Wieler, A B Micflikier.   

Abstract

Ambulatory 24-hour oesophageal pH studies were obtained from 11 patients with scleroderma who expressed either dysphagia (n = 6) or heartburn (n = 5) as their predominant oesophageal symptom. No significant differences were found in the extent of pattern of reflux between these two groups. The pH data of both scleroderma groups were combined and compared to an age- and sex-matched group of control subjects (n = 11). The reflux demonstrated by scleroderma patients was significantly greater than the control group in every category (P < 0.01). The percentage of time the pH was < 4.0 was not significantly different (P > 0.05) upright (29.9 +/- 19.8%) vs. supine (44.2 +/- 28.5%) in patients with scleroderma. Eight scleroderma patients underwent repeat pH studies while taking low-dose omeprazole (20 mg daily) and reflux was reduced significantly (P < 0.01) in all patients. The authors believe that 24-hour ambulatory oesophageal pH-monitoring should be routinely conducted in scleroderma patients to provide quantitative reflux data, even when heartburn is not expressed as a symptom. Omeprazole, 20 mg daily, provides adequate protection from the H+ component of the refluxate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280819     DOI: 10.1111/j.1365-2036.1993.tb00126.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Ambulatory esophageal pH testing. Referral patterns, indication, and treatment in a Canadian teaching hospital.

Authors:  J P Shoenut; C S Yaffe
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Impact of ingested liquids on 24-hour ambulatory pH tests.

Authors:  J P Shoenut; D Duerksen; C S Yaffe
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

3.  Reproducibility of ambulatory esophageal pH monitoring in the aperistaltic esophagus.

Authors:  J P Shoenut; A B Mieflikier; T A Aldor; C S Yaffe; D J Goldenberg
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

4.  Laparoscopic surgery for gastro-oesophageal reflux disease.

Authors:  D Alderson; C R Welbourn
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

5.  Gastroesophageal reflux disease and connective tissue disorders: pathophysiology and implications for treatment.

Authors:  Marco G Patti; Warren J Gasper; Piero M Fisichella; Ian Nipomnick; Francesco Palazzo
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

6.  Effect of severe gastroesophageal reflux on sleep stage in patients with aperistaltic esophagus.

Authors:  J P Shoenut; Y Yamashiro; W C Orr; P Kerr; A B Micflikier; M H Kryger
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.